Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Comparative Quantitative Benefit-Risk Assessment of High- and Low-Dose Methylprednisolone in Multiple Sclerosis Relapse Management
Stockholm University, Faculty of Social Sciences, Department of Computer and Systems Sciences. Uppsala Monitoring Centre (UMC), Sweden.
2014 (English)In: Pharmacoepidemiology and Drug Safety, ISSN 1053-8569, E-ISSN 1099-1557, Vol. 23, 238-238 p.Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
2014. Vol. 23, 238-238 p.
National Category
Pharmacology and Toxicology
Identifiers
URN: urn:nbn:se:su:diva-109014ISI: 000342763600448OAI: oai:DiVA.org:su-109014DiVA: diva2:769114
Note

AuthorCount:2;

Available from: 2014-12-05 Created: 2014-11-10 Last updated: 2017-12-05Bibliographically approved

Open Access in DiVA

No full text

Search in DiVA

By author/editor
Caster, Ola
By organisation
Department of Computer and Systems Sciences
In the same journal
Pharmacoepidemiology and Drug Safety
Pharmacology and Toxicology

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 31 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf